The state-owned pharmaceutical company, established by the government to address prevailing issues within the Maldivian healthcare sector, is currently undertaking significant initiatives. The most pressing public concerns include frequent medicine shortages, unavailability of essential drugs, high costs, and quality assurance issues. To provide a comprehensive solution to these challenges, the company is preparing to launch a robust digital system designed to monitor national medicine stocks and patient statistics. According to the company, this system will ensure that relevant authorities have seamless access to real-time information, leading to a sustainable resolution of these issues. Furthermore, a dedicated hotline has already been introduced to address and manage medicine-related complaints.
